Intensity Therapeutics INTS
NASDAQ INTS
$3.28 -0.01 (-0.30%)
As of: Oct 20, 2026 · 3:59 PM EDT

Intensity Therapeutics (INTS) Times Interest Earned (2022 - 2023)

Updated

Intensity Therapeutics' (INTS) Times Interest Earned was -27.28 for FY2023, compared with -92.07 in FY2022.

Analysis

Intensity Therapeutics (INTS) Times Interest Earned (2022 - 2023) Analysis & Trends

  • According to Business Quant data, Times Interest Earned came in at -92.07 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,137.84 Bn 1,106.42 Bn 19.71 Bn -
2 Johnson & Johnson 618.03 Bn 536.55 Bn 17.26 Bn 25.41
3 AbbVie 507.69 Bn 480.80 Bn 12.70 Bn -
4 Merck 366.91 Bn 321.28 Bn 12.21 Bn -
5 Novartis Ag 298.54 Bn 262.53 Bn 11.24 Bn 10.28
6 Astrazeneca 263.16 Bn 236.84 Bn 12.86 Bn 7.27
7 Amgen 236.31 Bn 191.71 Bn 7.24 Bn 5.22
8 Gilead Sciences 192.91 Bn 167.11 Bn 6.22 Bn -42.08
9 Pfizer 171.40 Bn 118.04 Bn 10.94 Bn -
10 Intensity Therapeutics 9.96 Mn -28.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -5.50
Mar 31, 2023 -15.11
Dec 31, 2022 -39.70
Sep 30, 2022 -116.90
Jun 30, 2022 -129.01
API Access

Intensity Therapeutics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=INTS&period=max&api_key=YOUR_API_KEY